Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02394964 · ClinicalTrials.gov registry record
The Human Microbiome in Immune-Mediated Diseases
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 75
- Enrollment target
NCT02394964 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 75 participants.
The verdict
NCT02394964 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
The immune system is influenced by the commensal microbes that live in the gut and on the skin. This study aims to characterize the microbiota of subjects with autoimmune disease in order to determine whether certain microbial species may cause or worsen immune-mediated diseases
Interventions
- OTHER Sample Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2014-11 |
| Est. Completion | 2023-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02394964
The ClinicalTrials.gov registry entry for NCT02394964 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sample Collection is the first listed.
NCT02394964 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02394964 about?
NCT02394964 is a clinical study titled "The Human Microbiome in Immune-Mediated Diseases". The immune system is influenced by the commensal microbes that live in the gut and on the skin. This study aims to characterize the microbiota of subjects with autoimmune disease in order to determine whether certain microbial species may cause or worsen immune-mediated diseases
What is the current status of trial NCT02394964?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2014-11. Estimated completion is 2023-12.
What interventions are being tested in trial NCT02394964?
The interventions under investigation include: Sample Collection (OTHER).
Who is sponsoring clinical trial NCT02394964?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.